A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2011
10/19/2011	EP2376118A1 Method for obtaining an excipient-free antibody solution
10/19/2011	EP2376117A1 Hepatitis c virus combination therapy
10/19/2011	EP2376116A2 Anti-igf antibodies
10/19/2011	EP2376115A1 Methods and systems for inducing immunologic tolerance to non-self antigens
10/19/2011	EP2376114A2 Mixing lyophilised meningococcal vaccines with non-hib vaccines
10/19/2011	EP2376113A1 Compositions and dosage regimes comprising a clostridial vaccine and levamisole
10/19/2011	EP2376112A2 MIXING LYOPHILISED MENINGOCOCCAL VACCINES WITH D-T-Pa VACCINES
10/19/2011	EP2376111A1 Polypeptides for inducing a protective immune response against staphylococcus aureus
10/19/2011	EP2376110A1 Weekly dosing regimens for anti-cd30 vc-pab-mmae antibody drug-conjugates
10/19/2011	EP2376109A1 Covalent diabodies and uses thereof
10/19/2011	EP2376108A2 IgE CH3 PEPTIDE VACCINE
10/19/2011	EP2376107A1 Immunostimulatory oligonucleotides
10/19/2011	EP2376105A1 Nkg2d-fc for immunotherapy
10/19/2011	EP2376082A1 Combination of aurora kinase inhibitors and anti-cd20 antibodies
10/19/2011	EP2375897A1 Methods and compositions containing mtor inhibitors for enhancing immune responses
10/19/2011	EP1995314B1 Method for production of erythro- or threo-2-amino-3-hydroxypropionic acid ester, novel carbonyl reductase, gene for the reductase, vector, transformant, and method for production of optically active alcohol using those
10/19/2011	EP1930346B1 Antibody produced using ostrich and method for production thereof
10/19/2011	EP1898949B1 Vaccination by transcutaneous targeting
10/19/2011	EP1709064B1 Dna sequence, and recombinant production of the grass pollen allergen lol p 4
10/19/2011	EP1687024B1 Carbohydrate antigen-nanoparticle conjugates and uses thereof as antimetastatic agents in treating cancer
10/19/2011	EP1573323B1 Prion protein ligands and methods of use
10/19/2011	EP1572918B1 Synthetic glyco-lipo-peptides as vaccines
10/19/2011	EP1563308B1 Methods and kits for diagnosing tumorigenicity
10/19/2011	EP1451338B1 Recombinant antibodies for the detection and neutralization of anthrax toxin
10/19/2011	EP1165132B1 Dry formulation for transcutaneous immunization
10/19/2011	CN1913919B HIV vaccines based on env of multiple clades of hiv
10/19/2011	CN102224237A Bacterial ghost (bg) production process using betapropiolactone (blp) for final inactivation
10/19/2011	CN102224170A Materials and methods for inhibiting cancer cell invasion related to fgfr4
10/19/2011	CN102224169A Polypeptides, antibody variable domains & antagonists
10/19/2011	CN102224168A Composition for producing anti-amyloid beta peptide antibodies with d-peptides
10/19/2011	CN102223897A Anti-angiogenesis therapy for the treatment of breast cancer
10/19/2011	CN102223896A Anti-beta-2-microglobulin agents and the use thereof
10/19/2011	CN102223895A Method for production of ph stable enveloped viruses
10/19/2011	CN102223894A Hiv/siv vaccines for the generation of mucosal and systemic immunity
10/19/2011	CN102223887A Method for treating parkinson's disease
10/19/2011	CN102221618A Method for establishing hog cholera lapinized virus labeled vaccine strain and preparing vaccine
10/19/2011	CN102220423A Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
10/19/2011	CN102220357A Multivalent vaccines comprising recombinant viral vectors
10/19/2011	CN102220293A Dog flu recombinant virus as well as preparation method and application thereof
10/19/2011	CN102220291A Duck flavivirus and inactivated vaccine thereof
10/19/2011	CN102220289A Cellular permissivity factor for viruses, and uses thereof
10/19/2011	CN102220287A Avian infectious bronchitis cold adaptation attenuated vaccine strain and application thereof
10/19/2011	CN102220272A Method for high density culture of haemophilus parasuis for preparing vaccines
10/19/2011	CN102220263A Mycoplasma bovis attenuated strain and application thereof
10/19/2011	CN102219858A Cryptosporidium parvum CTL multi-epitope gene and fusion protein and application thereof
10/19/2011	CN102219856A Vascular Endothelial Growth Factor (VEGF) acceptor 2/CD3 bispecific single-chain antibody
10/19/2011	CN102219855A High-affinity anti-EGFR (epidermal growth factor receptor) monoclonal antibody
10/19/2011	CN102219854A Monoclonal antibody of anti-human PIGF (placental growth factor) protein as well as preparation method and application thereof
10/19/2011	CN102219853A Anti-H5N1 type bird flue virus vicuna VHH heavy chain antibody as well as preparation method and application thereof
10/19/2011	CN102219837A Recombinant full-length A-type botulinum toxin mutant vaccine
10/19/2011	CN102219835A Long peptide based on HCA587 antigen and its application in preparing antitumor drugs
10/19/2011	CN102219750A N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
10/19/2011	CN102218139A Medicament for treating and/or preventing viral infection
10/19/2011	CN102218138A 免疫原性组合物 The immunogenic composition
10/19/2011	CN102218137A Vaccine
10/19/2011	CN102218136A Anti-reovirus oral gene engineering vaccine and its preparation method
10/19/2011	CN101550189B Anthropogenic antivirulin glycosidoprotein neutralizing genetic engineering antibody RD9 and preparation and application thereof
10/18/2011	US8039607 Probe, probe set, probe carrier, and testing method
10/18/2011	US8039605 Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment
10/18/2011	US8039603 Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
10/18/2011	US8039600 Monoclonal antibodies
10/18/2011	US8039599 Rapamycin assay
10/18/2011	US8039598 Met fab and SCFV fragments
10/18/2011	US8039597 Antibodies and related molecules that bind to 24P4C12 proteins
10/18/2011	US8039596 Alpha 5-beta 1 antibodies and their uses
10/18/2011	US8039595 Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylation
10/18/2011	US8039593 Antibodies and immunotoxins that target human glycoprotein NMB
10/18/2011	US8039592 Optimized Fc variants and methods for their generation
10/18/2011	US8039440 Peptides for inhibiting chemokine binding to chemokine receptors
10/18/2011	US8039434 Method for producing human insulin-like growth factor I
10/18/2011	US8039257 Pre-transplant accomodated organs resistant to anti-donor immunity
10/18/2011	US8039225 Method to identify patients at risk for lung transplant rejection
10/18/2011	US8039008 Identification of residues critical for the function of the vibrio cholerae virulence regulator ToxT by scanning alanine mutagenesis
10/18/2011	US8039007 Polypeptides from Neisseria meningitidis
10/18/2011	US8039006 Solid composition containing bacillus-type non-pathogenic bacterial spores
10/18/2011	US8039005 Mutant forms of streptolysin O
10/18/2011	US8039004 Methods of preparing myxomavirus compositions
10/18/2011	US8039003 Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis
10/18/2011	US8039002 Influenza hemagglutinin and neuraminidase variants
10/18/2011	US8039001 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
10/18/2011	US8039000 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
10/18/2011	US8038999 Breast cancer eradication program
10/18/2011	US8038998 Methods of cancer therapy targeted against a cancer stemline
10/18/2011	US8038997 Anti-marinobufagenin antibodies and methods for their use
10/18/2011	US8038996 Composition and method for cancer treatment
10/18/2011	US8038995 Human N-type calcium channel isoform and uses thereof
10/18/2011	US8038994 Synergistic administration of a xenotypic antibody and an anticarcinogenic agent; immunotherapy
10/18/2011	US8038993 Cytotoxic antibodies directed against antibodies inhibiting factor VIII
10/18/2011	US8038992 Target for regulating multiple sclerosis
10/18/2011	US8038986 Immunogenic compositions and diagnostic and therapeutic uses thereof
10/18/2011	CA2561800C Anti-gluten egg yolk antibodies for the treatment of celiac disease
10/18/2011	CA2470643C Cleavable reagents for specific delivery to disease sites
10/18/2011	CA2469459C Methods and compositions for the diagnosis of asthma
10/18/2011	CA2391843C Hcv vaccine compositions
10/18/2011	CA2381708C Immunogenic protein against piscirickettsia salmonis
10/18/2011	CA2311492C Vaccines with an ltb adjuvant
10/18/2011	CA2232237C Reagents and methods useful for detecting diseases of the breast
10/18/2011	CA2226575C Stabile isotonic lyophilized protein formulation
10/18/2011	CA2221682C Method of preparing a monoclonal antibody, monoclonal antibody, a pharmaceutical composition and a diagnostic reagent
10/18/2011	CA2213833C Vascular endothelial cell growth factor antagonists

1 ... 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 ... 1823